These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 9591271)

  • 1. Navigating biotechnology's new fiscal opportunities.
    Purcell DJ
    Nat Biotechnol; 1998 May; 16 Suppl():51-3. PubMed ID: 9591271
    [No Abstract]   [Full Text] [Related]  

  • 2. Sumitomo buys Oxford finance.
    Bouchie A
    Nat Biotechnol; 2004 Apr; 22(4):480. PubMed ID: 15085808
    [No Abstract]   [Full Text] [Related]  

  • 3. The changing attitude of European VCs.
    Mitchell P
    Nat Biotechnol; 2004 Apr; 22(4):479. PubMed ID: 15085807
    [No Abstract]   [Full Text] [Related]  

  • 4. Life support for life science innovation?
    Nat Biotechnol; 2007 Feb; 25(2):144. PubMed ID: 17287731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growing strong. Biotechnology's new wave hopes that being first will pay off.
    Erickson D
    Sci Am; 1992 Jan; 266(1):134, 136. PubMed ID: 1734508
    [No Abstract]   [Full Text] [Related]  

  • 6. Biotech entrepreneurs swoon over proposed fundraising changes.
    Venkataramanan M
    Nat Med; 2012 Jan; 18(1):3. PubMed ID: 22227645
    [No Abstract]   [Full Text] [Related]  

  • 7. The biotechnology innovation machine: a source of intelligent biopharmaceuticals for the pharma industry--mapping biotechnology's success.
    Evens RP; Kaitin KI
    Clin Pharmacol Ther; 2014 May; 95(5):528-32. PubMed ID: 24448474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Japanese firms broaden investment focus to early biotech.
    Louët S; Sipp D
    Nat Biotechnol; 2004 Aug; 22(8):931-2. PubMed ID: 15286631
    [No Abstract]   [Full Text] [Related]  

  • 9. The money men.
    Alper J
    Nat Biotechnol; 2003 Jul; 21 Suppl():BE7-12. PubMed ID: 12874970
    [No Abstract]   [Full Text] [Related]  

  • 10. Patent fight sparks biological warfare in the drug industry.
    Fortune; 2000 Jul; 142(3):40, 42. PubMed ID: 11066662
    [No Abstract]   [Full Text] [Related]  

  • 11. When times get tough.
    Jong S
    Nat Biotechnol; 2009 Mar; 27(3):226-8. PubMed ID: 19274868
    [No Abstract]   [Full Text] [Related]  

  • 12. The 802 million dollars fallacy.
    Hodgson J
    Nat Biotechnol; 2004 Sep; 22(9):1076. PubMed ID: 15340464
    [No Abstract]   [Full Text] [Related]  

  • 13. The service-based bioeconomy.
    Nat Biotechnol; 2014 Jul; 32(7):597. PubMed ID: 25004205
    [No Abstract]   [Full Text] [Related]  

  • 14. Innovation and compliance are not diametrically opposed.
    Raab GK
    Qual Assur; 1994 Mar; 3(1):2-8. PubMed ID: 7804614
    [No Abstract]   [Full Text] [Related]  

  • 15. Medical entrepreneurism: the current opportunity in America.
    Lexa FJ
    J Am Coll Radiol; 2004 Oct; 1(10):762-8. PubMed ID: 17411697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The stampede to convertibles.
    Jacobs T
    Nat Biotechnol; 2003 Aug; 21(8):855. PubMed ID: 12894195
    [No Abstract]   [Full Text] [Related]  

  • 17. Biotech venture capital--it's not too late to be early.
    Klausner A
    Nat Biotechnol; 2005 Apr; 23(4):417-8. PubMed ID: 15815662
    [No Abstract]   [Full Text] [Related]  

  • 18. Biotech patents-business as usual?
    Lawrence S
    Nat Biotechnol; 2008 Dec; 26(12):1326. PubMed ID: 19060861
    [No Abstract]   [Full Text] [Related]  

  • 19. Patent crunch pending.
    Wadman M
    Nature; 2007 Oct; 449(7163):651. PubMed ID: 17968400
    [No Abstract]   [Full Text] [Related]  

  • 20. Patenting Dr. Venter's genetic findings: is the National Institutes of Health creating hurdles or clearing the path for biotechnology's voyage in the twenty-first century?
    Riley PJ
    J Contemp Health Law Policy; 1994; 10():309-26. PubMed ID: 10134812
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.